Novolog Pharm Up 1966 Ltd

The company's capital structure is characterized by a debt-to-equity ratio of 0.51, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 0.91, suggesting that the company's current liabilities slightly exceed its current assets. The company reported negative operating cash flow of -726,000 ILS, but a positive free cash flow of 662,000 ILS, indicating some capacity to fund operations and investments. Profitability metrics show a return on equity of 1.15% and a return on assets of 0.19%, both of which are below the industry median for ground freight and logistics. The company's net income of 4.1 million ILS is modest relative to its revenue of 1.8 billion ILS, indicating low profitability. Gross profit of 137.5 million ILS suggests that the company is facing significant cost pressures, which may be impacting its margins. The company's revenue is not segmented by geographic region or business line in the available data, making it difficult to assess geographic exposure or segment performance. However, the company's operations are likely concentrated in the local market, given the lack of international revenue disclosure. This concentration could expose the company to regional economic and regulatory risks. The company's growth trajectory is uncertain, as the available data does not provide forward-looking revenue projections. The company's capital expenditure of -62.6 million ILS indicates a reduction in investment, which may signal a strategic shift or financial constraints. The absence of detailed growth plans or segment-specific outlooks makes it challenging to assess the company's future performance. The company's risk profile includes medium liquidity risk, as indicated by the current ratio of 0.91 and negative net cash position after subtracting total debt. The risk of dilution is assessed as low, with no significant dilution sources identified in the available data. The company's financial structure and operational performance suggest that it may face challenges in maintaining profitability and liquidity in the near term. Recent events and disclosures do not provide specific details on the company's strategic initiatives or financial performance beyond the reported financials. The company's last actual EPS was 0.06 ILS, and its last actual revenue was 839.8 million ILS, according to analyst estimates. These figures suggest a relatively stable but low-growth business model.